Eckenhoff R G, Johansson J S
Department of Anesthesia, University of Pennsylvania Medical Center, Philadelphia 19104-4283, USA.
Pharmacol Rev. 1997 Dec;49(4):343-67.
The fundamental interactions of inhalational anesthetics with proteins have been considered in some detail, using specific examples where appropriate to illustrate these interactions and demonstrate progress. It is now clear that these low-affinity volatile molecules with rapid kinetics can specifically bind to discrete sites in some proteins at reasonable pharmacological concentrations, and some general features of these sites are beginning to emerge. The structural or dynamic consequences of anesthetic binding, however, are still vague at best. The remaining challenge is to define which interactions produce anesthetic binding to relevant targets and what the features of this relevant anesthetic binding site are. Finally, and most importantly, how does the occupancy of these pockets, patches, or cavities result in the subtle alterations in protein conformation and dynamics that confound their function and ultimately produce the behavioral response that we term "anesthesia"?
吸入性麻醉剂与蛋白质之间的基本相互作用已得到较为详细的研究,文中适当列举了具体实例以阐释这些相互作用并展示研究进展。现在已经明确,这些具有快速动力学的低亲和力挥发性分子在合理的药理浓度下能够特异性地结合某些蛋白质中的离散位点,并且这些位点的一些一般特征也开始显现出来。然而,麻醉剂结合所产生的结构或动力学后果,充其量仍然模糊不清。剩下的挑战是确定哪些相互作用导致麻醉剂与相关靶点结合,以及这种相关麻醉剂结合位点的特征是什么。最后,也是最重要的,这些口袋、斑块或腔隙的占据如何导致蛋白质构象和动力学的细微变化,从而干扰其功能并最终产生我们称之为“麻醉”的行为反应?